Compare DERM & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | GCTS |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 185.8M |
| IPO Year | 2021 | 2021 |
| Metric | DERM | GCTS |
|---|---|---|
| Price | $4.30 | $1.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.75 | $3.20 |
| AVG Volume (30 Days) | 193.9K | ★ 1.8M |
| Earning Date | 11-16-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,858,000.00 | $2,866,000.00 |
| Revenue This Year | $25.29 | $232.78 |
| Revenue Next Year | $50.00 | $563.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $0.96 |
| 52 Week High | $9.56 | $3.93 |
| Indicator | DERM | GCTS |
|---|---|---|
| Relative Strength Index (RSI) | 36.54 | 27.77 |
| Support Level | $4.31 | $1.04 |
| Resistance Level | $5.50 | $1.43 |
| Average True Range (ATR) | 0.33 | 0.13 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 18.50 | 22.30 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.